Back

An Organotypic Oral Squamous Cell Carcinoma Model Recapitulates Epithelial-Stromal Complexity at Single-cell Resolution and Reveals Matrix-derived Signalling as a Therapeutic Target.

Yevlashevskaya, O. S.; Davies, J. Z.; Choi, J.; Yuan, S.; Latif, A.; Poologasundarampillai, G.; Gendoo, D. M. A.; Wiench, M.

2026-03-12 cancer biology
10.64898/2026.03.10.710769 bioRxiv
Show abstract

Three-dimensional (3D) organotypic cultures recapitulate key structural features of oral tumours and provide controlled, ethical, and reproducible research platforms. However, their ability to faithfully recapitulate in vivo tissue composition and their translational relevance require rigorous validation. Here, we characterised a head and neck squamous cell carcinoma (HNSCC) model using single-cell RNA sequencing to assess maturation, cellular heterogeneity, functionality, and inter- and intra-tissue interactions within epithelial and stromal compartments. The epithelial layer of the model differentiated into populations closely resembling the tissue of tumour origin, including dividing and precursor cells, heterogeneous basal layer, suprabasal cells, and metabolically specialised populations. All epithelial lineages emerged from proliferative progenitors, driven by dynamic transcription factor programmes. The collagen-rich stroma contained functionally diverse fibroblasts reflecting the heterogeneity of cancer-associated fibroblasts in vivo, including dividing, matrix-producing, immune-responsive, and tumour-like populations. Importantly, extensive epithelial-stromal communication networks developed, essential for cancer epithelium maintenance and tumour microenvironment regulation. Matrix-derived signals, particularly fibronectin, osteopontin, and laminins, constituted dominant inputs to CD44-expressing cancer cells and are associated with patient survival in HNSCC, highlighting potential therapeutic targets. Overall, this organotypic HNSCC model exhibits high functional fidelity, captures key tumour elements relevant for therapy and resistance and brings confidence in non-animal drug testing.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 6%
18.4%
2
Developmental Cell
168 papers in training set
Top 2%
8.3%
3
EMBO Molecular Medicine
85 papers in training set
Top 0.1%
8.3%
4
Cell Stem Cell
57 papers in training set
Top 0.4%
4.3%
5
Advanced Science
249 papers in training set
Top 5%
3.9%
6
Cell Reports Medicine
140 papers in training set
Top 1%
3.9%
7
Science Advances
1098 papers in training set
Top 6%
3.5%
50% of probability mass above
8
Cell Reports
1338 papers in training set
Top 17%
3.0%
9
The EMBO Journal
267 papers in training set
Top 0.7%
2.6%
10
Molecular Cancer
14 papers in training set
Top 0.2%
2.1%
11
Genome Medicine
154 papers in training set
Top 4%
1.9%
12
Cancer Cell
38 papers in training set
Top 1%
1.7%
13
Nature Cell Biology
99 papers in training set
Top 3%
1.7%
14
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 35%
1.5%
15
Nature Genetics
240 papers in training set
Top 5%
1.5%
16
Cancer Research
116 papers in training set
Top 2%
1.5%
17
eLife
5422 papers in training set
Top 45%
1.5%
18
Scientific Reports
3102 papers in training set
Top 67%
1.2%
19
JCI Insight
241 papers in training set
Top 5%
1.1%
20
Science Translational Medicine
111 papers in training set
Top 4%
1.1%
21
Cell Genomics
162 papers in training set
Top 5%
0.9%
22
Cell
370 papers in training set
Top 15%
0.9%
23
Disease Models & Mechanisms
119 papers in training set
Top 2%
0.9%
24
Communications Biology
886 papers in training set
Top 22%
0.8%
25
Molecular Therapy
71 papers in training set
Top 3%
0.7%
26
Oncogene
76 papers in training set
Top 2%
0.7%
27
Clinical Cancer Research
58 papers in training set
Top 2%
0.7%
28
Cancer Discovery
61 papers in training set
Top 2%
0.7%
29
Stem Cell Reports
118 papers in training set
Top 1%
0.7%
30
Nature Materials
21 papers in training set
Top 1%
0.6%